Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to BullFrogAI.com
BullFrog AI Holdings, Inc.
  • Overview
  • News & Events
    • Press Releases
    • In The News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Back to BullFrogAI.com

Press Releases

News & Events

News & Events

  • Press Releases
  • In The News
  • IR Calendar
  • Presentations
  • Email Alerts
Oct 15, 2024 7:30 am EDT

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

Oct 09, 2024 7:30 am EDT

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Aug 26, 2024 8:00 am EDT

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Jul 25, 2024 7:30 am EDT

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

May 29, 2024 8:00 am EDT

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

May 16, 2024 8:00 am EDT

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

Apr 09, 2024 8:00 am EDT

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

Mar 08, 2024 8:00 am EST

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

Feb 26, 2024 8:00 am EST

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

Feb 21, 2024 12:01 pm EST

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
©2025 BullFrog AI Holdings, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap